Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Nov 1;98(9):2167–2173. doi: 10.1172/JCI119023

In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.

M Yudkoff 1, Y Daikhin 1, I Nissim 1, A Jawad 1, J Wilson 1, M Batshaw 1
PMCID: PMC507662  PMID: 8903337

Abstract

We developed a new technique that monitors metabolic competency in female heterozygotes for ornithine transcarbamylase deficiency (OTCD). The method uses mass spectrometry to measure conversion of (15)NH4Cl to [15N]urea and [5-(15)N]glutamine following an oral load of (15)NH4Cl. We found that heterozygotes converted significantly less NH3 nitrogen to urea, with this difference being particularly obvious for symptomatic carriers, in whom the blood [15N]urea concentration (mM) was significantly less than control values at most time points. The blood concentration of [5-(15)N]-glutamine (microM) was significantly higher in both asymptomatic and symptomatic heterozygotes than it was in the control subjects. The administration of a test dose of sodium phenylbutyrate to the control group did not affect the rate of [15N]urea formation. We conclude: (a) This test effectively monitors in vivo N metabolism and might obviate the need for liver biopsy to measure enzyme activity in OTCD; (b) Asymptomatic OTCD carriers form urea at a normal rate, indicating that ureagenesis can be competent even though enzyme activity is below normal; (c) Although ostensibly asymptomatic OTCD carriers form urea at a normal rate, their nitrogen metabolism is still abnormal, as reflected in their increased production of [5-(15)N]glutamine; and (d) This new test may be important for monitoring the efficacy of novel treatments for OTCD, e.g., liver transplantation and gene therapy.

Full Text

The Full Text of this article is available as a PDF (180.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arn P. H., Hauser E. R., Thomas G. H., Herman G., Hess D., Brusilow S. W. Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. A cause of postpartum coma. N Engl J Med. 1990 Jun 7;322(23):1652–1655. doi: 10.1056/NEJM199006073222307. [DOI] [PubMed] [Google Scholar]
  2. Batshaw M. L. Inborn errors of urea synthesis. Ann Neurol. 1994 Feb;35(2):133–141. doi: 10.1002/ana.410350204. [DOI] [PubMed] [Google Scholar]
  3. Batshaw M. L., Msall M., Beaudet A. L., Trojak J. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency. J Pediatr. 1986 Feb;108(2):236–241. doi: 10.1016/s0022-3476(86)80989-1. [DOI] [PubMed] [Google Scholar]
  4. Brusilow S. W., Danney M., Waber L. J., Batshaw M., Burton B., Levitsky L., Roth K., McKeethren C., Ward J. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N Engl J Med. 1984 Jun 21;310(25):1630–1634. doi: 10.1056/NEJM198406213102503. [DOI] [PubMed] [Google Scholar]
  5. Brusilow S., Tinker J., Batshaw M. L. Amino acid acylation: a mechanism of nitrogen excretion in inborn errors of urea synthesis. Science. 1980 Feb 8;207(4431):659–661. doi: 10.1126/science.6243418. [DOI] [PubMed] [Google Scholar]
  6. Burlina A. B., Ferrari V., Dionisi-Vici C., Bordugo A., Zacchello F., Tuchman M. Allopurinol challenge test in children. J Inherit Metab Dis. 1992;15(5):707–712. doi: 10.1007/BF01800010. [DOI] [PubMed] [Google Scholar]
  7. Dahms W. T., Owens R. P., Kalhan S. C., Kerr D. S., Danish R. K. Urea synthesis, nitrogen balance, and glucose turnover in growth-hormone-deficient children before and after growth hormone administration. Metabolism. 1989 Mar;38(3):197–203. doi: 10.1016/0026-0495(89)90075-9. [DOI] [PubMed] [Google Scholar]
  8. Elsas L. J., Ellerine N. P., Klein P. D. Practical methods to estimate whole body leucine oxidation in maple syrup urine disease. Pediatr Res. 1993 May;33(5):445–451. doi: 10.1203/00006450-199305000-00005. [DOI] [PubMed] [Google Scholar]
  9. Fomon S. J., Bier D. M., Matthews D. E., Rogers R. R., Edwards B. B., Ziegler E. E., Nelson S. E. Bioavailability of dietary urea nitrogen in the breast-fed infant. J Pediatr. 1988 Sep;113(3):515–517. doi: 10.1016/s0022-3476(88)80643-7. [DOI] [PubMed] [Google Scholar]
  10. Grompe M., Jones S. N., Loulseged H., Caskey C. T. Retroviral-mediated gene transfer of human ornithine transcarbamylase into primary hepatocytes of spf and spf-ash mice. Hum Gene Ther. 1992 Feb;3(1):35–44. doi: 10.1089/hum.1992.3.1-35. [DOI] [PubMed] [Google Scholar]
  11. Hauser E. R., Finkelstein J. E., Valle D., Brusilow S. W. Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women. N Engl J Med. 1990 Jun 7;322(23):1641–1645. doi: 10.1056/NEJM199006073222305. [DOI] [PubMed] [Google Scholar]
  12. Jones B. N., Gilligan J. P. o-Phthaldialdehyde precolumn derivatization and reversed-phase high-performance liquid chromatography of polypeptide hydrolysates and physiological fluids. J Chromatogr. 1983 Aug 26;266:471–482. doi: 10.1016/s0021-9673(01)90918-5. [DOI] [PubMed] [Google Scholar]
  13. Lehnert W., Sperl W., Suormala T., Baumgartner E. R. Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients. Eur J Pediatr. 1994;153(7 Suppl 1):S68–S80. doi: 10.1007/BF02138781. [DOI] [PubMed] [Google Scholar]
  14. Long C. L., Jeevanandam M., Kinney J. M. Metabolism and recycling of urea in man. Am J Clin Nutr. 1978 Aug;31(8):1367–1382. doi: 10.1093/ajcn/31.8.1367. [DOI] [PubMed] [Google Scholar]
  15. Matsuda I., Nagata N., Matsuura T., Oyanagi K., Tada K., Narisawa K., Kitagawa T., Sakiyama T., Yamashita F., Yoshino M. Retrospective survey of urea cycle disorders: Part 1. Clinical and laboratory observations of thirty-two Japanese male patients with ornithine transcarbamylase deficiency. Am J Med Genet. 1991 Jan;38(1):85–89. doi: 10.1002/ajmg.1320380119. [DOI] [PubMed] [Google Scholar]
  16. Matthews D. E., Downey R. S. Measurement of urea kinetics in humans: a validation of stable isotope tracer methods. Am J Physiol. 1984 Jun;246(6 Pt 1):E519–E527. doi: 10.1152/ajpendo.1984.246.6.E519. [DOI] [PubMed] [Google Scholar]
  17. Morsy M. A., Alford E. L., Bett A., Graham F. L., Caskey C. T. Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J Clin Invest. 1993 Sep;92(3):1580–1586. doi: 10.1172/JCI116739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Patterson B. W., Carraro F., Klein S., Wolfe R. R. Quantification of incorporation of [15N]ammonia into plasma amino acids and urea. Am J Physiol. 1995 Sep;269(3 Pt 1):E508–E515. doi: 10.1152/ajpendo.1995.269.3.E508. [DOI] [PubMed] [Google Scholar]
  19. Rosenblatt J., Chinkes D., Wolfe M., Wolfe R. R. Stable isotope tracer analysis by GC-MS, including quantification of isotopomer effects. Am J Physiol. 1992 Sep;263(3 Pt 1):E584–E596. doi: 10.1152/ajpendo.1992.263.3.E584. [DOI] [PubMed] [Google Scholar]
  20. Rowe P. C., Newman S. L., Brusilow S. W. Natural history of symptomatic partial ornithine transcarbamylase deficiency. N Engl J Med. 1986 Feb 27;314(9):541–547. doi: 10.1056/NEJM198602273140903. [DOI] [PubMed] [Google Scholar]
  21. Schwenk W. F., Berg P. J., Beaufrere B., Miles J. M., Haymond M. W. Use of t-butyldimethylsilylation in the gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Anal Biochem. 1984 Aug 15;141(1):101–109. doi: 10.1016/0003-2697(84)90431-7. [DOI] [PubMed] [Google Scholar]
  22. Stratford-Perricaudet L. D., Levrero M., Chasse J. F., Perricaudet M., Briand P. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther. 1990 Fall;1(3):241–256. doi: 10.1089/hum.1990.1.3-241. [DOI] [PubMed] [Google Scholar]
  23. Takahashi H., Koehler R. C., Brusilow S. W., Traystman R. J. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol. 1991 Sep;261(3 Pt 2):H825–H829. doi: 10.1152/ajpheart.1991.261.3.H825. [DOI] [PubMed] [Google Scholar]
  24. Todo S., Starzl T. E., Tzakis A., Benkov K. J., Kalousek F., Saheki T., Tanikawa K., Fenton W. A. Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology. 1992 Mar;15(3):419–422. doi: 10.1002/hep.1840150311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tuchman M., Holzknecht R. A., Gueron A. B., Berry S. A., Tsai M. Y. Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism. Pediatr Res. 1992 Nov;32(5):600–604. doi: 10.1203/00006450-199211000-00024. [DOI] [PubMed] [Google Scholar]
  26. Wareham K. A., Howell S., Williams D., Williams E. D. Studies of X-chromosome inactivation with an improved histochemical technique for ornithine carbamoyltransferase. Histochem J. 1983 Apr;15(4):363–371. doi: 10.1007/BF01002969. [DOI] [PubMed] [Google Scholar]
  27. Wolfe R. R., Goodenough R. D., Burke J. F., Wolfe M. H. Response of protein and urea kinetics in burn patients to different levels of protein intake. Ann Surg. 1983 Feb;197(2):163–171. doi: 10.1097/00000658-198302000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yudkoff M., Yang W., Snodgrass P. J., Segal S. Ornithine transcarbamylase deficiency in a boy with normal development. J Pediatr. 1980 Mar;96(3 Pt 1):441–443. doi: 10.1016/s0022-3476(80)80694-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES